prikaz prve stranice dokumenta Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
  Download
PDF 2.86 MB
Scientific paper - Review paper
Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
World Journal of Clinical Cases, 9 (2021), 20; 5398-5407. https://doi.org/10.12998/wjcc.v9.i20.5398
Mikulić, Danko; Mrzljak, Anna

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Mikulić, D. & Mrzljak, A. (2021). Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy. World Journal of Clinical Cases, 9. (20), 5398-5407. doi: 10.12998/wjcc.v9.i20.5398

Mikulić, Danko and Anna Mrzljak. "Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy." World Journal of Clinical Cases, vol. 9, no. 20, 2021, pp. 5398-5407. https://doi.org/10.12998/wjcc.v9.i20.5398

Mikulić, Danko and Anna Mrzljak. "Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy." World Journal of Clinical Cases 9, no. 20 (2021): 5398-5407. https://doi.org/10.12998/wjcc.v9.i20.5398

Mikulić, D. and Mrzljak, A. (2021) 'Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy', World Journal of Clinical Cases, 9(20), pp. 5398-5407. doi: 10.12998/wjcc.v9.i20.5398

Mikulić D, Mrzljak A. Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy. World Journal of Clinical Cases [Internet]. 2021 July 16 [cited 2024 May 08];9(20):5398-5407. doi: 10.12998/wjcc.v9.i20.5398

D. Mikulić and A. Mrzljak, "Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy", World Journal of Clinical Cases, vol. 9, no. 20, pp. 5398-5407, July 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:549397. [Accessed: 08 May 2024]

Metadata
Title (english)Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
AuthorDanko Mikulić
AuthorAnna Mrzljak
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
While pancreatic cancer is still characterized by early systemic spread and poor outcomes, the treatment of this disease has changed significantly in recent years due to major advancements in systemic therapy and advanced surgical techniques. Broader use of effective neoadjuvant approaches combined with aggressive surgical operations within a multidisciplinary setting has improved outcomes. Borderline resectable pancreatic cancer is characterized by tumor vascular invasion, and is a setting where the combination of potent neoadjuvant chemotherapy and aggressive surgical methods, including vascular resections and reconstructions, shows its full potential. Hopefully, this will lead to improved local control and curative treatment in a number of patients with this aggressive malignancy.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleWorld Journal of Clinical Cases
Numberingvol. 9, no. 20, pp. 5398-5407
e-ISSN2307-8960
DOIhttps://doi.org/10.12998/wjcc.v9.i20.5398
URN:NBNurn:nbn:hr:105:549397
Publication2021-07-16
Document URLhttps://www.wjgnet.com/2307-8960/full/v9/i20/5398.htm
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) icon
Created on2022-06-02 08:40:12